Conditions: Acne Vulgaris
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 503
Healthy volunteers: no

Brief summary:
The study hypothesis are based on the assumption that :

* CD0271 0.3%/CD1579 2.5% Gel provides superior clinical efficacy compared with Topical Gel Vehicle in the overall population and in the subgroup of severe Subjects
* CD0271 0.3%/CD1579 2.5% Gel applied once daily for up to 12 weeks has an acceptable safety and tolerability profile

Detailed description:

Arms:
arm 1: active arm arm 2: Comparator arm arm 3: Placebo arm

Interventions: intervention 1: CD0271 0.3% / CD1579 2.5% intervention 2: CD0271 0.1% / CD1579 2.5% intervention 3: Topical Gel Vehicle
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: